Inhaled corticosteroid dose-reducing effect of omalizumab in patients with controlled, severe asthma according to usage of inhaled long-acting beta-agonists
Authors:
- Kian Fan ChungKCKian Fan Chung
- Stephen HolgateSHStephen Holgate
- John O'BRienJOJohn O'BRien
- Howard FoxHFHoward Fox
- Jackie ThirlwellJTJackie Thirlwell
- 1 January 2002
- journal article
- abstracts
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 109 (1) , S239